AMLX NASDAQ
Amylyx Pharmaceuticals, Inc.
1W: -6.9%
1M: +35.4%
3M: +127.3%
YTD: +176.9%
1Y: +167.3%
3Y: +49.2%
$31.62
-0.47 (-1.46%)
Weekly Expected Move ±33.1%
$11
$21
$32
$42
$53
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.5B
52W Range10.83-41.14
Volume1,712,676
Avg Volume2,090,641
Beta-0.20
Dividend—
Analyst Ratings
Company Info
CEOJoshua Cohen
Employees136
SectorHealthcare
IndustryBiotechnology
IPO Date2022-01-07
Websiteamylyx.com
55 Cambridge Parkway
Cambridge, MA 02142
US
Cambridge, MA 02142
US
617 682 0917
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
Latest News
Legal & General Group Plc Takes Position in Amylyx Pharmaceuticals, Inc. $AMLX
Is GLP-1 Stock Amylyx Still a Buy After Skyrocketing 247%?
Should Eli Lilly Investors Be Worried About a Threat From Amylyx?
BlackRock Inc. Acquires New Stake in Amylyx Pharmaceuticals, Inc. $AMLX
BlackRock Inc. Acquires New Stake in Amylyx Pharmaceuticals, Inc. $AMLX
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| FRATES JAMES M | A-Award | 22,807 | — | 2026-08-18 |
| Klee Justin B. | A-Award | 60,039 | — | 2026-08-18 |
| Mazzariello Gina | A-Award | 21,284 | — | 2026-08-18 |
| Bedrosian Camille L | A-Award | 22,807 | — | 2026-08-18 |
| Cohen Joshua B | A-Award | 60,039 | — | 2026-08-18 |